How much funding has Medial EarlySign raised?

Medial EarlySign has raised $30.0M in total funding, most recently a Series B round.

Who are Medial EarlySign's investors?

Medial EarlySign's investors include aMoon, Horizons Ventures.

When was Medial EarlySign founded?

Medial EarlySign was founded in 2013.

Where is Medial EarlySign headquartered?

Medial EarlySign is headquartered in Herzliya, Israel.

What industry is Medial EarlySign in?

Medial EarlySign operates in Artificial Intelligence, Healthcare.

How many employees does Medial EarlySign have?

Medial EarlySign has 11-50 employees.

Medial EarlySign

Herzliya, Israel · Founded 2013 · $30.0M raised

Artificial Intelligence

Healthcare

Headquarters: Herzliya
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: earlysign.com
Total Funding: $30.0M
Last Round: $30.0M Series BMar 2018
Rounds: 1

About

Medial EarlySign develops machine learning-based clinical decision support tools that extract hidden predictive signals from standard electronic health record (EHR) data, enabling early detection and prevention of high-burden diseases such as cancer, diabetes, and heart failure. The company's algorithmic platform processes billions of medical data elements to generate thousands of personalized parameters, setting individualized risk levels for mass patient populations in real time. Its solutions target healthcare organizations—including large hospital systems and managed care organizations—and are validated through clinical trials across more than 5 million patients at 14 leading research institutions worldwide.

Summary

Medial EarlySign is an Artificial Intelligence company based in Herzliya, Israel, founded in 2013. It has raised $30.0M in total across 1 round, most recently a $30.0M Series B round in Mar 2018. Investors include aMoon and Horizons Ventures.